Why the study?
Outpatient treatment of deep vein thrombosis is preferred over inpatient treatment, but evidence is lacking regarding how best to identify ideal candidates.
Does a pharmacist-driven screening tool efficiently identify ED patients with DVT appropriate for outpatient management?
Does a pharmacist-driven screening tool efficiently identify ED patients with DVT appropriate for outpatient management?
A pharmacist-driven screening tool was found to be inefficient for identifying ED patients with DVT appropriate for outpatient management, as the vast majority of admitted patients did not meet eligibility criteria.
Answers are grounded in this paper and cite their sources.
Tool may inefficiently select ED DVT patients for outpatient care; leaves open prospective evaluation of adjusted eligibility criteria.
BACKGROUND: Deep vein thrombosis (DVT) is a critical and costly health issue. Treatment in the outpatient setting is preferred compared to the inpatient setting. However, there is a lack of evidence regarding how best to identify patients who are ideal for outpatient DVT treatment. OBJECTIVE: To design and evaluate a pharmacist-driven screening tool for the identification of patients presenting to the emergency department (ED) at a community hospital with DVT who are appropriate for outpatient treatment. METHODS: This study was conducted in sequential phases: compilation and vetting of screening criteria, descriptive evaluation of criteria through retrospective chart review, and quantification of potential cost savings by avoiding admissions. Criteria were collected via literature search and assembled into a screening tool, which was applied retroactively to a cohort of ED patients admitted with DVT diagnosis. RESULTS: A screening tool was developed with multidisciplinary input and consisted of 5 categories with individual patient and disease state criteria. The majority (91%) of patients reviewed would not have qualified for outpatient DVT treatment based on the retrospective application of the screening tool. The most common disqualification criteria category was high risk of bleeding/clotting (n = 81), and the most frequently represented parameter within that category was antithrombotic therapy prior to admission (n = 53). CONCLUSION: A screening tool may not be the most efficient method for health-care practitioners such as pharmacists to identify ED patients appropriate for outpatient management of DVT. Other avenues should be explored for improving the cost-effective management of these patients.
No takes yet. Share an insight, caveat, or question.
Musco et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: